On the recordApril 25, 2022
Congress charged the FDA, not CMS, to be the agency responsible for evaluating the safety and efficacy of biomedical products.
Source
congress.govCongress charged the FDA, not CMS, to be the agency responsible for evaluating the safety and efficacy of biomedical products.
Senator Collins emphasizes FDA's primary role in evaluating biomedical product safety.
Share
More from Susan Collins
It’s a critical program and the foundation of retirement income for most Mainers, and I’ve voted repeatedly to preserve it.
There’s only one of us on this stage who has always been pro-choice, and that’s me.